BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36350738)

  • 1. Association of Urinary Biomarkers of Smoking-Related Toxicants with Lung Cancer Incidence in Smokers: The Multiethnic Cohort Study.
    Cigan SS; Murphy SE; Stram DO; Hecht SS; Marchand LL; Stepanov I; Park SL
    Cancer Epidemiol Biomarkers Prev; 2023 Mar; 32(3):306-314. PubMed ID: 36350738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of urinary biomarkers of tobacco exposure with lung cancer risk in African American and White cigarette smokers in the Southern Community Cohort Study.
    Murphy SE; Guillermo C; Thomson NM; Carmella SG; Wittmann M; Aldrich MC; Cai Q; Sullivan SM; Stram DO; Le Marchand L; Hecht SS; Blot WJ; Park SL
    Cancer Epidemiol Biomarkers Prev; 2024 May; ():. PubMed ID: 38780906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
    Park SL; Murphy SE; Wilkens LR; Stram DO; Hecht SS; Le Marchand L
    PLoS One; 2017; 12(5):e0178435. PubMed ID: 28542511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco-specific N-nitrosamine exposures and cancer risk in the Shanghai Cohort Study: remarkable coherence with rat tumor sites.
    Stepanov I; Sebero E; Wang R; Gao YT; Hecht SS; Yuan JM
    Int J Cancer; 2014 May; 134(10):2278-83. PubMed ID: 24243522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers.
    Yuan JM; Gao YT; Murphy SE; Carmella SG; Wang R; Zhong Y; Moy KA; Davis AB; Tao L; Chen M; Han S; Nelson HH; Yu MC; Hecht SS
    Cancer Res; 2011 Nov; 71(21):6749-57. PubMed ID: 22028322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.
    Yuan JM; Koh WP; Murphy SE; Fan Y; Wang R; Carmella SG; Han S; Wickham K; Gao YT; Yu MC; Hecht SS
    Cancer Res; 2009 Apr; 69(7):2990-5. PubMed ID: 19318550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of Exposure and Potential Harm among Natural American Spirit Smokers.
    Carroll DM; Allenzara A; Jensen J; Stepanov I; Hecht S; Murphy S; Luo X; Donny E; Hatsukami DK
    Tob Regul Sci; 2019 Jul; 5(4):339-351. PubMed ID: 33457467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.
    Carmella SG; Heskin AK; Tang MK; Jensen J; Luo X; Le CT; Murphy SE; Benowitz NL; McClernon FJ; Vandrey R; Allen SS; Denlinger-Apte R; Cinciripini PM; Strasser AA; al'Absi M; Robinson JD; Donny EC; Hatsukami DK; Hecht SS
    PLoS One; 2019; 14(4):e0215853. PubMed ID: 31022220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
    Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Cotinine Is as Good a Biomarker as Serum Cotinine for Cigarette Smoking Exposure and Lung Cancer Risk Prediction.
    Thomas CE; Wang R; Adams-Haduch J; Murphy SE; Ueland PM; Midttun Ø; Brennan P; Johansson M; Gao YT; Yuan JM
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):127-132. PubMed ID: 31685561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotinine and tobacco-specific carcinogen exposure among nondaily smokers in a multiethnic sample.
    Khariwala SS; Scheuermann TS; Berg CJ; Hayes RB; Nollen NL; Thomas JL; Guo H; Ahluwalia JS; Benowitz NL
    Nicotine Tob Res; 2014 May; 16(5):600-5. PubMed ID: 24297808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships Between Race, Gender, and Spot Urine Levels of Biomarkers of Tobacco Exposure Vary Based on How Creatinine Is Handled in Analyses.
    Carroll DM; Cigan S; Ikuemonisan J; Hammonds T; Stepanov I; St Helen G; Benowitz N; Hatsukami DK
    Nicotine Tob Res; 2020 Oct; 22(11):2109-2113. PubMed ID: 32598452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menthol cigarettes, race/ethnicity, and biomarkers of tobacco use in U.S. adults: the 1999-2010 National Health and Nutrition Examination Survey (NHANES).
    Jones MR; Apelberg BJ; Tellez-Plaza M; Samet JM; Navas-Acien A
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):224-32. PubMed ID: 23250935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic Differences of Urinary Cadmium in Cigarette Smokers from the Multiethnic Cohort Study.
    Cigan SS; Murphy SE; Alexander BH; Stram DO; Hatsukami DK; Le Marchand L; Park SL; Stepanov I
    Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33800899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study.
    Rostron BL; Wang J; Etemadi A; Thakur S; Chang JT; Bhandari D; Botelho JC; De Jesús VR; Feng J; Gail MH; Inoue-Choi M; Malekzadeh R; Pourshams A; Poustchi H; Roshandel G; Shiels MS; Wang Q; Wang Y; Xia B; Boffetta P; Brennan P; Abnet CC; Calafat AM; Wang L; Blount BC; Freedman ND; Chang CM
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of Exposure among U.S. Adult Cigar Smokers: Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
    Chang CM; Rostron BL; Chang JT; Corey CG; Kimmel HL; Sosnoff CS; Goniewicz ML; Edwards KC; Hatsukami DK; Wang Y; Del Valle-Pinero AY; Yang M; Travers MJ; Arnstein S; Taylor K; Conway K; Ambrose BK; Borek N; Hyland A; Wang L; Blount BC; van Bemmel DM
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):943-953. PubMed ID: 30733305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.
    Vogel RI; Carmella SG; Stepanov I; Hatsukami DK; Hecht SS
    Biomarkers; 2011 Sep; 16(6):491-7. PubMed ID: 21812592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cessation of cigarette smoking on eicosanoid biomarkers of inflammation and oxidative damage.
    McElroy JP; Carmella SG; Heskin AK; Tang MK; Murphy SE; Reisinger SA; Jensen JA; Hatsukami DK; Hecht SS; Shields PG
    PLoS One; 2019; 14(6):e0218386. PubMed ID: 31251764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine.
    Stepanov I; Hecht SS; Lindgren B; Jacob P; Wilson M; Benowitz NL
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1382-6. PubMed ID: 17627002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.